alzheimer's disease and imaging

BNET Resources

• sort by:
• Relevance
• Date
• Popularity

Avid Announces Results of AV-1 Molecular Imaging Agent for Alzheimer's Disease Presented at AD/PD Meeting

First in a Series of Novel [eth]-Amyloid Imaging Compounds from the University of Pennsylvania

Tags: Alzheimer's disease, Avid Technology Inc., imaging, Molecular Inc.

Research articles 2007-03-19

Siemens and UCLA Researchers Get FDA "Green Light" for Clinical Study of Alzheimer's-Specific Imaging Agent

Study Will Measure the Safety of One of the First Imaging Biomarkers Designed to Differentiate Alzheimer's Disease from Other Forms of Dementia

Tags: Alzheimer's disease, FDA, imaging, Siemens AG, University of California at Los Angeles

Research articles 2006-12-20

Future Medical Technologies May Identify the Early Onset of Alzheimer's and Enable Stem Cell Therapy; Molecular Imaging Advancements Simultaneously Locate, Diagnose and Treat Disease

CHICAGO -- Siemens Medical Solutions today revealed its vision for a new world of medicine where doctors can predict and prevent disease before symptoms appear. By identifying and tracking disease-related events in the body's cells, Siemens envisions that, among other applications, molecular medicine will have a tremendous impact on the...

Tags: Alzheimer's disease, imaging, Molecular Inc., stem-cell

Research articles 2005-11-29

Phase I Data from Avid Radiopharmaceuticals' Alzheimer's and Parkinson's Disease Imaging Programs to be Presented at the 55th Annual Society of Nuclear Medicine Meeting

Presentations Highlight Proof of Concept Results for Avid's Novel Molecular Imaging Agents

Tags: Alzheimer's disease, Avid Technology Inc., imaging

Research articles 2008-06-12

Imaging Agent from Avid Radiopharmaceuticals to Be Licensed by Bayer Schering Pharma for Early Detection of Alzheimer's Disease

PHILADELPHIA -- Avid Radiopharmaceuticals, Inc. Avid, a product-focused molecular imaging company, and Bayer Schering Pharma, a world leader in the diagnostic imaging pharmaceutical field, today announced that Bayer Schering Pharma has exercised its right to license Avid's 18F-AV1/ZK compound, a molecular imaging agent that targets amyloid plaques in the brain....

Tags: Alzheimer's disease, Avid Technology Inc., Bayer AG, imaging, pharmaceutical company, Schering

Research articles 2007-06-19

UNIVERSITY OF OXFORD, AMERSHAM HEALTHCARE, AND BRISTOL-MYERS SQUIBB SIGN AGREEMENT INVOLVING TEST FOR ALZHEIMER'S DISEASE; New imaging technique could speed detection, help evaluate new treatments, and receive expedited review at FDA

ARLINGTON HEIGHTS, Ill.--HealthWire--March 29, 1996-- Medi-Physics Inc., Amersham Healthcare announced today a licensing agreement between its UK-based parent, Amersham International plc, Bristol-Myers Squibb Company (NYSE: BMY), and the University of Oxford, one of Britain's premier universities and medical centers. The agreement will likely result in Medi-Physics petitioning the U.S. Food...

Tags: agreement, Alzheimer's disease, Bristol-Myers Squibb Co., FDA, imaging, technique, University of Oxford

Research articles 1996-03-29